z-logo
open-access-imgOpen Access
GEN-003 Phase 2 Interim Results: Therapeutic Vaccine for Genital Herpes Significantly Reduces Viral Shedding and Genital Lesions
Author(s) -
Nicholas Van Wagoner,
William Koltun,
Gregg Lucksinger,
Terri Warren,
Stephen K. Tyring,
David Bernstein,
Peter A. Leone,
Lori Panther,
Jacob Lalezari,
Kenneth H. Fife,
Richard Novák,
Richard H. Beigi,
John D. Kriesel,
Jason Chan,
Sybil Tasker,
Seth Hetherington,
Anna Wald
Publication year - 2015
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofv133.615
Subject(s) - medicine , genital herpes , interim , viral shedding , virology , sex organ , genital tract , herpes genitalis , virus , herpes simplex virus , physiology , archaeology , biology , history , genetics
RESULTS: Patient Demographics 898 1The University of Alabama at Birmingham, Birmingham, AL, 2Medical Center for Clinical Research, San Diego, CA, 3Tekton Research, Austin, TX, 4Westover Heights Clinic, Portland, OR, 5Center for Clinical Studies, Houston, TX, 6Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 7University of North Carolina, Chapel Hill, NC, 8Beth Israel Deaconess Medical Center, Boston, MA, 9Quest Clinical Research, San Francisco, CA, 10Indiana University School of Medicine, Indianapolis, IN, 11University of Illinois at Chicago, Chicago, IL, 12Magee Women’s Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA, 13University of Utah School of Medicine, Salt Lake City, UT, 14IND 2 Results LLC, Atlanta, GA , 15Genocea Biosciences, Cambridge, MA, 16University of Washington, Seattle, WA

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom